Back to search

National and Kapodistrian University of Athens

Διερεύνηση του μηχανισμού δράσης της ηπατικής διεγερτικής ουσίας ( HSS) στην κίρρωση

Abstract

dc:description

Liver fibrosis is a wound healing process activated in cases of chronic liverdamage, as in the case of alcohol abuse or chronic viral hepatitis. The maincharacteristics of this process is the death of hepatocytes, the attempts for tissueregeneration, inflammation, oxidative stress and the persistent activation of cells, suchas HSC, which have fibre proliferating abilities. The latter produce collagen as well asother extracellular matrix ingredients causing fibrosis.Cirrhosis is the result of the liver fibrotic process which is characterized bydeposition of fibrous scar in all tissue, development of nodules of regeneratinghepatocytes, disruption of the entire liver architecture and a decline in the liver’sfunction. Owing to the fact that this condition leads to high death rates, researchfocuses on discerning the mechanisms causing fibrosis. The use of animal models hasproved to be of extreme help. Chronic administration of TAA to rats is one of themost common models used in order to reproduce the characteristics of viral cirrhosisin humans.Recent findings show the possibility of regression not only of fibrosis but alsoof cirrhosis in animal models. Human cirrhosis is the result of a chronic fibroticprocess. Its characteristic is the increased linkage of the extracellular matrix so it isdifficult to be reversed. A more realistic approach towards the treatment of cirrhosis isthe administration of antifibrotic therapy before cirrhosis sets in.HSS is a liver specific growth factor. It is secreted during acute liver injuryand in connection with other growth factors it helps towards the creation of newtissue, through liver regeneration.In this thesis, HSS activity has been calculated in rats’ liver during cirrhosisinduction. HSS was continuously produced during this process peaking in animalswith severe fibrosis. In cases of cirrhosis, though, HSS was significantly reduced. Asimilar pattern was noticed for hepatic proliferative activity. In the second part of thisstudy, the growth factor was administered to rats, in the final stage of cirrhosisinduction, externally, along with TAA. HSS served as a shield to the tissue reducingthe extent of fibrosis and preventing cirrhosis. This was made through increasing theregenerative capacity of the liver.The findings show, that HSS plays an active role in the liver’s regenerativeprocess during cirrhosis induction. It is also obvious that the stimulation of liver136regeneration through the administration of growth factors, such as HSS, could serveas an alternative therapy towards the prevention of cirrhosis. In this regard, liverspecificity of HSS assigns a considerable advantage to HSS compared to otherfactors

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gribilas, Georgios
  • Γρίμπιλας, Γεώργιος

Subjects

dc:subject × 28

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29494

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gribilas, Georgios; Γρίμπιλας, Γεώργιος. Διερεύνηση του μηχανισμού δράσης της ηπατικής διεγερτικής ουσίας ( HSS) στην κίρρωση. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/29494